The results of complement fixation tests on 202 sera from people without cancer and from patients with cancer in 29 different areas of the body indicated that only those with nine varieties of advanced cancer (lip, mouth, oropharynx, nasopharynx, kidney, urinary bladder, prostate, cervix uteri, and vulva-all antibodies demonstrable by comllement fixation (11, 13) .
the cervix uteri gave positive results. The seven patients with advanced cancer of the lip or oropharynx gave positive reactions with HSV 1 but not with HSV 2 nonvirion antigens (compatible with involvement of only HSV 1), all of the 13 women with advanced cancer of the cervix uteri and the one woman with advanced cancer of the vulva gave positive reactions with both HSV 1 and HSV 2 nonvirion antigens (compatible with involvement of only HSV 2), while among the 35 other positive patients only two (one with cancer of the kidney and one with cancer of the bladder) reacted with HSV 1 and not at all with HSV 2 nonvirion antigens. Positive sera failed to react with cells harvested at different times after high-multiplicity infection with the DNA vaccinia virus. Massive absorption of positive sera with trypsinized, uninfected human embryonic kidney cells failed to remove, or lower the titer of, the HSV 1 and HSV 2 nonvirion antibodies.
All of these data taken together are interpreted as indicating that HSV 1 and HSV 2 play an etiologic role in certain human cancers, because they provide the kind of Abbreviations: HSV 1, herpes simplex (labialis) virus, subtype 1; HSV 2, herpes simplex (genitalis) virus, subtype 2; GPK, guinea pig kidney; RK, rabbit kidney; HEp2, a human cell line derived from an epidermoid carcinoma of the larynx; PFU, plaque-forming unit. * antibodies demonstrable by comllement fixation (11, 13 Absorption of Virion Antibody from Human and Guinea Pig Sera before Tests for Nonvirion Antibody. The basic procedures for absorption were described (3, 11) . Although storage at about 40 had been found to eliminate HSV 1 and HSV 2 nonvirion reactivity from infected HEp2 cell suspensions between 7 and 9 days and between 12 and 15 days, respectively (11, 13), when 0.1-ml quantities were being tested, the very much larger quantities (100-times or more) required for absorption of the human and guinea pig sera might still contain enough nonvirion antigen at 14 days to reduce the titer of nonvirion antibody in the absorbed sera. Moreover, the original observations (11, 13) were not made under conditions of strict temperature control (an ordinary refrigerator that was opened many times each day had been used); we could not assume that under the conditions of storage used in the present work (an infrequently used walk-in refrigerator carefully controlled and monitored at 40 + 0.50) the nonvirion antigens would be inactivated at the same rate. We indeed found that the standard guinea pig sera gave much lower nonvirion antibody titers when they were absorbed with HEp2 cell suspensions stored at the strictly controlled 40 temperature for [2] [3] [4] weeks, while storage for 5-8 weeks yielded higher titers of nonvirion antibody without loss of capacity to remove the virion antibody. A mixture of equal parts of HSV 1 (Table 3) is remarkably in accord with the observations that high-multiplicity infection of tissue culture cells with HSV 1 strains has induced antigens which on hyperimmunization of guinea pigs produced antibodies that react with HSV 1 and not with HSV 2 nonvirion antigens (13). These results suggest the possibility of a special involvement of HSV 1 in these cancers, unlike that associated with ordinary primary and recurrent infections with this virus. Similarly, the fact that the sera of all 14 patients with advanced carcinoma of the cervix uteri or vulva, areas commonly infected by HSV 2, reacted with both HSV 1 and HSV 2 nonvirion antigens is remarkably in accord with the observations that high-multiduring virion absorption. A described procedure for the comProc. Nat. Acad. Sci. USA 70 (1978) plicity infection of tissue cultures with HSV 2, which has in- The following control tests were done to establish the specificity of the antibodies in the positive cancer sera for nonvirion antigens coded by HSV genetic material: (a) 10 Positive sera (two each of nasopharynx, bladder, kidney, prostrate, and cervix uteri) failed to react with cells, harvested 10 min and 6 hr after high-multiplicity infection with the DNA vaccinia virus, which produces, within 10 min (12), a transitory marked rise in concentration of a preexisting normal antigen that is also present in greater concentration in almost all transformed and malignant human cells; (b) the antibodies in the same 10 sera were not removed or diminished in titer by massive absorption with freshly harvested HEp2 cells; and (c) the antibodies in four positive sera (two each of kidney and cervix uteri) were not removed or diminished in titer by massive absorption with freshly trypsinized cells from the kidneys of 12-to 14-week-old human embryos. These results, taken together with the other manifestations of specificity (Tables  2 and 3) , strongly support the conclusion that the antibodies we demonstrated in the positive human cancer sera were indeed against neoantigens coded in one group of cancers (oropharynx and lip) by HSV 1 and in the other group of cancers (cervix uteri, vulva, and with a few possible exceptions also prostate, bladder, kidney, and nasopharynx) by HSV 2. It is, therefore, all the more intriguing why all five oropharyngeal cancers are so strictly associated only with HSV 1 while at least nine of ten (and perhaps all) nasopharyngeal cancers are so definitely associated with HSV 2.
The results in Table 4 , showing the titers of the HSV 1 and HSV 2 nonvirion antibodies for each positive serum, are of interest especially because of the large number of sera that were positive only at the 1:4 dilution. Had we started our tests with a 1:10 dilution of serum and used the micro complement fixation procedure, as was done in the negative tests with various adenovirus T (tumor) antigens and unabsorbed sera (15) 
